Tony Fonk

This panel will explore the critical challenges and innovative solutions in the last mile of the pharmaceutical cold chain. Industry experts will discuss strategies to ensure temperature integrity, enhance patient-centric delivery, and foster collaboration between pharma companies, 3PL providers, and healthcare partners.

·        Discuss emerging technologies, regulatory compliance, and sustainable practices

·        Optimize the safe and efficient delivery of temperature-sensitive therapies to their final destination

·        Identify common challenges and lessons learned

As more therapies and specialty products are delivered directly to patients’ homes, maintaining end-to-end temperature control has never been more critical—or more complex. The ship-to-home model introduces unique challenges in packaging, tracking, and patient handoff that demand innovative solutions.

This panel brings together supply chain and cold chain leaders to explore how pharmaceutical companies are evolving their temperature monitoring strategies to meet the growing demands of at-home delivery while ensuring product integrity, patient safety, and regulatory compliance.

• Building real-time visibility and control into the last mile
• Choosing the right level of monitoring: active, passive, or hybrid models
• Aligning packaging, technology, and courier services for at-home shipments
• Mitigating risk in unpredictable patient environments